148 related articles for article (PubMed ID: 19018022)
1. Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
Sivagurunathan N; Krishnan S; Rao JV; Nagappa AN; Subrahmanyam VM; Vanathi BM
J Med Microbiol; 2008 Dec; 57(Pt 12):1514-1517. PubMed ID: 19018022
[TBL] [Abstract][Full Text] [Related]
2. Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.
Jean SS; Liao CH; Sheng WH; Lee WS; Hsueh PR
J Microbiol Immunol Infect; 2017 Aug; 50(4):454-463. PubMed ID: 26454423
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
Pankey GA; Ashcraft DS
Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
[TBL] [Abstract][Full Text] [Related]
4. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Xu W; Chen X
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
Gao C; Tong J; Yu K; Sun Z; An R; Du Z
Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
Eliopoulos GM; Klimm K; Ferraro MJ; Moellering RC
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):624-6. PubMed ID: 2506024
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
Pei G; Mao Y; Sun Y
Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
[TBL] [Abstract][Full Text] [Related]
10. Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.
Hardy DJ; Barry AL; Fuchs PC; Gerlach EH; McLaughlin JC; Pfaller MA
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):926-30. PubMed ID: 1486889
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species.
Gradelski E; Valera L; Bonner D; Fung-Tomc J
Antimicrob Agents Chemother; 2001 Nov; 45(11):3220-2. PubMed ID: 11600384
[TBL] [Abstract][Full Text] [Related]
12. The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
Chang PC; Chen CC; Lu YC; Lai CC; Huang HL; Chuang YC; Tang HJ
J Microbiol Immunol Infect; 2018 Apr; 51(2):207-213. PubMed ID: 29037802
[TBL] [Abstract][Full Text] [Related]
13. Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Cai Y; Yang D; Wang J; Wang R
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):186-190. PubMed ID: 29486972
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
Dawis MA; Isenberg HD; France KA; Jenkins SG
J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
[TBL] [Abstract][Full Text] [Related]
15. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1991 Feb; 44(2):130-9. PubMed ID: 2041154
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
[TBL] [Abstract][Full Text] [Related]
17. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
Chandrasekar PH; Sluchak JA
Infection; 1991; 19(1):49-53. PubMed ID: 2013510
[TBL] [Abstract][Full Text] [Related]
18. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
[TBL] [Abstract][Full Text] [Related]
19. [In vitro antibacterial activity of cefoperazone-sulbactam].
Zhang Y; Zhang J; Zhou L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
